Investing.com - Nextgen Healthcare (NASDAQ: NXGN) reported second quarter EPS of $0.31, $0.06 better than the analyst estimate of $0.25. Revenue for the quarter came in at $176.42M versus the consensus estimate of $176.96M.
Nextgen Healthcare's stock price closed at $23.86. It is up 47.65% in the last 3 months and up 27.46% in the last 12 months.
Nextgen Healthcare saw 0 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See Nextgen Healthcare's stock price’s past reactions to earnings here.
According to InvestingPro, Nextgen Healthcare's Financial Health score is "great performance".
Check out Nextgen Healthcare's recent earnings performance, and Nextgen Healthcare's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar